ROCHESTER, Minn. — A new Mayo Clinic study suggests a blood test could help predict whether a cognitively healthy person might develop memory problems or dementia within the next five to 10 years.
The study, published in JAMA Neurology, looked at combining a blood measure of a protein called phosphorylated Tau 217, or p-tau217, with a person’s age, sex and genetic risk to estimate their future chances of cognitive decline. Higher p-tau217 levels and older age were both linked to greater risk.
“The goal is to provide a personalized estimate of the risk of developing cognitive impairment that is more meaningful than simply reporting whether a blood test is positive or negative for amyloid pathology,” said Alicia Algeciras-Schimnich, a Mayo Clinic laboratory medicine and pathology researcher and first author of the study…